The seasonal affective disorder (SAD) therapeutics market is pegged at around US$ 848.2 million in 2022, with a modest Y-o-Y increase of 4.3% over 2022, according to a recent intelligence report by Future Market Insights. While drugs and devices collectively contribute to the consumption volume of seasonal affective disorder therapeutics, the latter will remain a major …